CITY OF HOPE, an innovative biomedical research, treatment and educational institution, is dedicated to the prevention and cure of cancer and other life-threatening diseases, guided by a compassionate patient-centered philosophy, and supported by a national foundation of humanitarian philanthropy. The CITY OF HOPE COMPREHENSIVE CANCER CENTER (COHCCC) is an independent biomedical research institution comprised of a National Medical Center and the Beckman Research Institute. Located in Duarte, California, 15 miles northeast of downtown Los Angeles, it is a founding member of the National Comprehensive Cancer Network (NCCN) and maintains the NCCN’s Oncology Outcomes Database. The COHCCC has highly regarded cancer-related research programs in bone marrow transplantation, gene therapy, stem cell and developmental biology, bioinformatics, immunotherapy, molecular biology and genetics, and quality of life and long-term survival.
COHCCC’s translational research program has had, and
continues to have, a major impact on the care of patients with cancer.
The Center conducts dozens of COH investigator-initiated clinical trials,
many of which are supported by successful Investigational New Drug (IND)
applications from the FDA. The Center’s facility for the production
of new biological agents against cancer was the first academic facility
in the world to support, in one dedicated building, “GMP” processing
for nucleic acids and viruses, as well as genetically
engineered antibodies and human cells. At any point in time, COHCCC patients
have available
to them dozens of clinical trials that provide state-of-the-art
treatment.
|
